[CH2:1]([O:4][C:5]([NH:7][C@@H:8](C)[CH2:9][C:10]([O:12][CH3:13])=[O:11])=[O:6])[CH:2]=[CH2:3].[C:15](OCC)(=O)[CH:16]=C.[H-].[Na+].Cl.[C:25]([OH:28])(=O)[CH3:26].[C:29]([BH3-])#N.[Na+]>C1(C)C=CC=CC=1.CO>[OH:28][CH:25]1[CH2:26][C@H:15]([CH3:16])[N:7]([C:5]([O:4][CH2:1][CH:2]=[CH2:3])=[O:6])[CH2:8][CH:9]1[C:10]([O:12][CH2:13][CH3:29])=[O:11]To a solution of methyl (3S)-3-{[(allyloxy)carbonyl]amino}butanoate (2.06 g, 10.2 mmol) and ethyl acrylate (1.11 ml, 10.2 mmol) in toluene (25 ml) was added at 40° C. sodium hydride (60% suspension in oil, 0.41 g, 10.2 mmol). The mixture was stirred for 2 hours and then was poured into diluted hydrochloric acid. The solution was extracted twice with ethyl acetate. The organic layer was washed with a saturated aqueous sodium chloride solution and dried over magnesium sulfate. The organic solvent was removed in vacuo. To the residue were added methanol (40 ml), acetic acid (0.70 ml, 12.2 mmol) and sodium cyanoborohydride (0.77 g, 12.2 mmol) and the mixture was stirred at room temperature for 20 minutes. The solvent was removed in vacuo and the residue was purified with silica gel chromatography to give a mixture (1.21 g) of 1-allyl 3-ethyl (6S)-4-hydroxy-6-methyl-1,3-piperidinedicarboxylate and 1-allyl 3-methyl (6S)-4-hydroxy-6-methyl-1,3-piperidinedicarboxylate.
読み込み中…
